These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 22562431)

  • 1. Cardiovascular mortality in psoriasis and psoriatic arthritis: epidemiology, pathomechanisms, therapeutic implications, and perspectives.
    Boehncke WH; Boehncke S
    Curr Rheumatol Rep; 2012 Aug; 14(4):343-8. PubMed ID: 22562431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
    Boehncke WH; Boehncke S
    G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.
    Boehncke WH; Boehncke S; Tobin AM; Kirby B
    Exp Dermatol; 2011 Apr; 20(4):303-7. PubMed ID: 21410760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Diseases in Psoriasis and Psoriatic Arthritis.
    Eder L; Dey A; Joshi AA; Boehncke WH; Mehta NN; Szentpetery A
    J Rheumatol Suppl; 2019 Jun; 95():20-27. PubMed ID: 31154400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review.
    Brezinski EA; Follansbee MR; Armstrong EJ; Armstrong AW
    Curr Pharm Des; 2014; 20(4):513-28. PubMed ID: 23565632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
    Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
    Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comorbidities in psoriasis].
    Weisenseel P; Prinz JC
    Dtsch Med Wochenschr; 2010 Jul; 135(28-29):1446-50. PubMed ID: 20614408
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
    Armstrong AW; Gelfand JM; Boehncke WH; Armstrong EJ
    J Rheumatol; 2013 Aug; 40(8):1434-7. PubMed ID: 23908540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meeting.
    Boehncke WH
    J Rheumatol; 2012 Feb; 39(2):441-4. PubMed ID: 22298277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiometabolic Disorders in Psoriatic Disease.
    Sobchak C; Eder L
    Curr Rheumatol Rep; 2017 Aug; 19(10):63. PubMed ID: 28844116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
    Tobin AM; Veale DJ; Fitzgerald O; Rogers S; Collins P; O'Shea D; Kirby B
    J Rheumatol; 2010 Jul; 37(7):1386-94. PubMed ID: 20472927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis comorbidities.
    Gottlieb AB; Chao C; Dann F
    J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence.
    Johnsson H; McInnes IB; Sattar N
    Ann Rheum Dis; 2012 Apr; 71(4):480-3. PubMed ID: 22294632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report.
    Fan JM; Solomon DA; López GY; Hofmann JW; Colorado RA; Kim AS; Meisel K; Halabi C
    BMC Neurol; 2020 Mar; 20(1):106. PubMed ID: 32199449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comorbidities and psoriasis. Impact on clinical practice].
    Gerdes S; Mrowietz U
    Hautarzt; 2012 Mar; 63(3):202-13. PubMed ID: 22373901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
    Cooksey R; Brophy S; Kennedy J; Gutierrez FF; Pickles T; Davies R; Piguet V; Choy E
    Semin Arthritis Rheum; 2018 Dec; 48(3):367-373. PubMed ID: 29656791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.
    Peluso R; Caso F; Tasso M; Ambrosino P; Dario Di Minno MN; Lupoli R; Criscuolo L; Caso P; Ursini F; Puente AD; Scarpa R; Costa On Behalf Of CaRRDs Study Group L
    Rev Recent Clin Trials; 2018; 13(3):199-209. PubMed ID: 29542417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.